Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review

Plazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacteria. It is effective against many bacteria-producing carbapenemases or other specific hydrolases. This scoping review aims to define the role acquired by plazomicin fr...

Full description

Bibliographic Details
Main Authors: Aniello Alfieri, Sveva Di Franco, Valerio Donatiello, Vincenzo Maffei, Ciro Fittipaldi, Marco Fiore, Francesco Coppolino, Pasquale Sansone, Maria Caterina Pace, Maria Beatrice Passavanti
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/12/12/1949
_version_ 1797456734024892416
author Aniello Alfieri
Sveva Di Franco
Valerio Donatiello
Vincenzo Maffei
Ciro Fittipaldi
Marco Fiore
Francesco Coppolino
Pasquale Sansone
Maria Caterina Pace
Maria Beatrice Passavanti
author_facet Aniello Alfieri
Sveva Di Franco
Valerio Donatiello
Vincenzo Maffei
Ciro Fittipaldi
Marco Fiore
Francesco Coppolino
Pasquale Sansone
Maria Caterina Pace
Maria Beatrice Passavanti
author_sort Aniello Alfieri
collection DOAJ
description Plazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacteria. It is effective against many bacteria-producing carbapenemases or other specific hydrolases. This scoping review aims to define the role acquired by plazomicin from its approval by the FDA (US Food and Drug Administration) in 2018 to the present day. Furthermore, we aim to provide a base for a future meta-analysis. This project was conducted following the recommendations presented in the PRISMA extension for scoping reviews and the JBI Manual for Evidence Synthesis. Among 901 potentially engaging citations, 345 duplicates were removed, and only 81 articles were selected for the analysis. According to the data analysis, plazomicin has been used to treat urinary tract infections, bloodstream infections, and ventilation-associated pneumonia. The pathogens killed included multi-resistant <i>E. coli</i>, <i>K. pneumoniae</i>, <i>A. baumannii</i>, <i>P. aeruginosa</i>, and <i>S. aureus</i>. Plazomicin can be a manageable, valid non-beta-lactam alternative for treating multi-resistant bacteria infections.
first_indexed 2024-03-09T16:12:06Z
format Article
id doaj.art-824a59dcf2f94af0b1c94f475b50cc2f
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T16:12:06Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-824a59dcf2f94af0b1c94f475b50cc2f2023-11-24T16:10:57ZengMDPI AGLife2075-17292022-11-011212194910.3390/life12121949Plazomicin against Multidrug-Resistant Bacteria: A Scoping ReviewAniello Alfieri0Sveva Di Franco1Valerio Donatiello2Vincenzo Maffei3Ciro Fittipaldi4Marco Fiore5Francesco Coppolino6Pasquale Sansone7Maria Caterina Pace8Maria Beatrice Passavanti9Department of Elective Surgery, Postoperative Intensive Care Unit and Hyperbaric Oxygen Therapy, A.O.R.N. Antonio Cardarelli, Viale Antonio Cardarelli 9, 80131 Naples, ItalyDepartment of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, ItalyDepartment of Elective Surgery, Postoperative Intensive Care Unit and Hyperbaric Oxygen Therapy, A.O.R.N. Antonio Cardarelli, Viale Antonio Cardarelli 9, 80131 Naples, ItalyDepartment of Elective Surgery, Postoperative Intensive Care Unit and Hyperbaric Oxygen Therapy, A.O.R.N. Antonio Cardarelli, Viale Antonio Cardarelli 9, 80131 Naples, ItalyUnit of Critical Care, Hospital “Ospedale Pellegrini”, Via Portamedina alla Pignasecca 41, 80134 Naples, ItalyDepartment of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, ItalyDepartment of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, ItalyDepartment of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, ItalyDepartment of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, ItalyDepartment of Women, Child and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Piazza Miraglia 2, 80138 Naples, ItalyPlazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacteria. It is effective against many bacteria-producing carbapenemases or other specific hydrolases. This scoping review aims to define the role acquired by plazomicin from its approval by the FDA (US Food and Drug Administration) in 2018 to the present day. Furthermore, we aim to provide a base for a future meta-analysis. This project was conducted following the recommendations presented in the PRISMA extension for scoping reviews and the JBI Manual for Evidence Synthesis. Among 901 potentially engaging citations, 345 duplicates were removed, and only 81 articles were selected for the analysis. According to the data analysis, plazomicin has been used to treat urinary tract infections, bloodstream infections, and ventilation-associated pneumonia. The pathogens killed included multi-resistant <i>E. coli</i>, <i>K. pneumoniae</i>, <i>A. baumannii</i>, <i>P. aeruginosa</i>, and <i>S. aureus</i>. Plazomicin can be a manageable, valid non-beta-lactam alternative for treating multi-resistant bacteria infections.https://www.mdpi.com/2075-1729/12/12/1949antimicrobial resistancebloodstream infectionsmulti-resistant <i>Enterobacterales</i>pyelonephritisplazomicinscoping review
spellingShingle Aniello Alfieri
Sveva Di Franco
Valerio Donatiello
Vincenzo Maffei
Ciro Fittipaldi
Marco Fiore
Francesco Coppolino
Pasquale Sansone
Maria Caterina Pace
Maria Beatrice Passavanti
Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
Life
antimicrobial resistance
bloodstream infections
multi-resistant <i>Enterobacterales</i>
pyelonephritis
plazomicin
scoping review
title Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
title_full Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
title_fullStr Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
title_full_unstemmed Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
title_short Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
title_sort plazomicin against multidrug resistant bacteria a scoping review
topic antimicrobial resistance
bloodstream infections
multi-resistant <i>Enterobacterales</i>
pyelonephritis
plazomicin
scoping review
url https://www.mdpi.com/2075-1729/12/12/1949
work_keys_str_mv AT anielloalfieri plazomicinagainstmultidrugresistantbacteriaascopingreview
AT svevadifranco plazomicinagainstmultidrugresistantbacteriaascopingreview
AT valeriodonatiello plazomicinagainstmultidrugresistantbacteriaascopingreview
AT vincenzomaffei plazomicinagainstmultidrugresistantbacteriaascopingreview
AT cirofittipaldi plazomicinagainstmultidrugresistantbacteriaascopingreview
AT marcofiore plazomicinagainstmultidrugresistantbacteriaascopingreview
AT francescocoppolino plazomicinagainstmultidrugresistantbacteriaascopingreview
AT pasqualesansone plazomicinagainstmultidrugresistantbacteriaascopingreview
AT mariacaterinapace plazomicinagainstmultidrugresistantbacteriaascopingreview
AT mariabeatricepassavanti plazomicinagainstmultidrugresistantbacteriaascopingreview